In 2019, GARDP launched “5 BY 25”, an initiative to develop five new antibiotic treatments during the period 2020-2025. Part of a broader strategy, 5 BY 25 signaled GARDP’s ambition to develop its R&D and access portfolio and expand its role in global efforts to counter antibiotic resistance. This webinar will take stock of what GARDP has accomplished and learned over the past five years, and how it is now leveraging progress to advance sustainable antibiotic R&D and access focused on public health needs.
Speakers
- Anand Anandkumar – Bugworks
- Manica Balasegaram – GARDP
- Glenda Gray – SAMRC
- David Paterson – ADVANCE-ID
Moderated by Herman Goossens, University of Antwerp.
This live webinar including interactive Q&A session will be broadcast on 15 January 2026 12:00 – 13:00 CET. You can find your timezone here.
If you have questions or comments, please let us know: revive@gardp.org.